Filtered By:
Source: Neurology
Condition: Lupus
This page shows you your search results in order of date.
Order by Relevance | Date
Total 12 results found since Jan 2013.
Predictive Variables of Cognitive Dysfunction in Patients with Lupus (P1.340)
Conclusions:Duration of disease and low educational level are predictors of CD in patients with SLE. Depression and anxiety did not influence cognitive performance. Although cardiovascular comorbidity is a risk factor for dementia in general population, those variables might play a minor role in SLE patients.Study Supported by:Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and São Paulo Research Foundation (FAPESP) (grant #2015/08833-7) supported this study.Disclosure: Dr. Alessi has nothing to disclose. Dr. Dutra Antonio has nothing to disclose. Dr. Maria has nothing...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Alessi, H., Dutra, L. A., Maria, L., Xavier, P., Couce, P., Kayser, C., Barsottini, O. Tags: CNS Inflammatory Diseases and Differential Diagnosis I Source Type: research
Diffusion Weighted Imaging in a Case of Longitudinally Extensive Transverse Myelitis in Neuromyelitis Optica (P6.395)
Conclusions:Limited data exist on DWI and ADC patterns in demyelinating disease, particularly for NMO and LETM. Understanding these neuroimaging patterns in patients who cannot receive gadolinium is important in diagnosing NMO and providing prompt treatment.Disclosure: Dr. Gluck has nothing to disclose. Dr. Vollbracht has received personal compensation for activities with Teva as a speaker.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Gluck, L., Vollbracht, S. Tags: Neuromyelitis Optica Spectrum Disorder, Transverse Myelitis, and Optic Neuritis B Source Type: research
Incidence of Ischemic Stroke in Young Adults, a 4 Year Retrospective Review from an Urban Tertiary Care Center in North Philadelphia (P3.232)
Conclusions: The incidence of Ischemic Stroke in this cohort is much higher than that reported in other observational studies. Despite an extensive work up, a cause was not found in the majority of patients. These data support the need for a more in depth investigation of the causes of stroke in the young in urban, underserved communities. Standard of care diagnostic tests fail to explain the unusually high incidence of Ischemic Stroke in this cohort.Disclosure: Dr. Pirastehfar has nothing to disclose. Dr. Katz has nothing to disclose. Dr. Gentile has nothing to disclose. Dr. Jacobi has nothing to disclose. Dr. Linares has...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Pirastehfar, M., Katz, P., Gentile, N., Jacobi, J., Linares, G. Tags: Stroke in the Young Source Type: research
HSV-2 Encephalitis Presenting as Multifocal Ischemic Stroke (P4.375)
CONCLUSION A high index of suspicion needs to be maintained to diagnose infectious vasculitis. A history of immunosuppression and headache preceding cerebral infarction were important factors that ultimately led to the appropriate work up and diagnosis in this case. Lumbar puncture and prompt initiation of antiviral treatment is essential in stroke case of suspected CNS infection with HSV-2.Disclosure: Dr. Zhang has nothing to disclose. Dr. Sumida has nothing to disclose. Dr. Margolesky has nothing to disclose. Dr. Tornes has nothing to disclose. Dr. Ramos has nothing to disclose. Dr. Koch has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Zhang, F., Sumida, A., Margolesky, J., Tornes, L., Ramos, A., Koch, S. Tags: Cerebrovascular Case Reports Source Type: research
Is it ever lupus? A single centre retrospective review of the rheumatologic work-up in patients with clinically isolated syndrome (P6.113)
Conclusions: In our single centre review of patients with CIS who underwent rheumatologic testing, ANA was weakly/moderately positive in 64[percnt] and did not aid in predicting diagnosis of MS versus an autoimmune rheumatologic disease. More specific rheumatologic markers, including ds-DNA, ENA, low C3/C4 and antiphospholipid antibodies were rarely positive, and no CIS was attributed to a newly diagnosed rheumatologic disease.Disclosure: Dr. Budhram has nothing to disclose. Dr. Yuen has nothing to disclose. Dr. Yan has nothing to disclose. Dr. Kremenchutzky has received research support from Bayer, Biogen Idec, Genzyme, N...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Budhram, A., Yuen, J., Yan, H., Kremenchutzky, M. Tags: MS and CNS Inflammatory Disease: CNS Inflammatory Diseases and Differential Diagnosis Source Type: research
Temporal Trends of Mortality in Acute Ischemic Stroke in Systemic Lupus Erythematosus: A Propensity-Matched Analysis of Nationwide Inpatient Data (P2.295)
CONCLUSIONS: Mortality in patient with SLE and AIS has significantly decreased from 2000 to 2011. Additionally, there was no difference in mortality between patients with and without SLE after propensity matching, suggesting that SLE has a minimal independent effect beyond traditional risk factors.Disclosure: Dr. Patel has nothing to disclose. Dr. Nadkarni has nothing to disclose. Dr. Mahajan has nothing to disclose. Dr. Konstantinidis has nothing to disclose. Dr. Simoes has nothing to disclose. Dr. Benjo has nothing to disclose. Dr. Kumar Agarwal has nothing to disclose. Dr. Pakanati has nothing to disclose. Dr. Menon has...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Patel, A., Nadkarni, G., Mahajan, A., Konstantinidis, I., Simoes, P., Benjo, A., Kumar Agarwal, S., Pakanati, K., Menon, M., Annapureddy, N. Tags: Cerebrovascular Disease and Interventional Neurology: Inflammation and Immunology Source Type: research
Spinal Cord Infarction as the Initial Presentation of Systemic Lupus Erythematosus (P2.077)
CONCLUSIONS:Aggressive therapy with high dose corticosteroids and intravenous cyclophosphamide followed by oral therapy may be a successful therapeutic approach to spinal cord infarcts secondary to systemic lupus erythematosus. Study Supported by: N/ADisclosure: Dr. Michael has nothing to disclose. Dr. Hayat has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Michael, A., Hayat, G. Tags: Neurological Consequences of Autoimmune Disease Source Type: research
Antiphospholipid Antibodies, Brain Infarcts, And Cognitive And Motor Decline In Aging (ABICMA): Final Cerebral Infarct Results from a Community-Based, Longitudinal, Clinical-Pathological Study (S62.002)
CONCLUSIONS: Overall aPL+ at baseline, proximal to death, or persistent aPL+ are not independent risk factors for BI in the elderly.Study Supported by: NIH grants R01HL96944, R01AG040039, P30AG10161, R01AG15819, R01AG17917, R01 AG24480Disclosure: Dr. Levine has received personal compensation in an editorial capacity for MedLink. Dr. Levine has received royalty payments as editor of a book. Dr. Arvanitakis has received personal compensation for activities with Vista Health. Dr. Arvanitakis has received research support from Ceregene, Inc. Dr. Brey has received personal compensation in an editorial capacity for Neurology Now...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Levine, S., Arvanitakis, Z., Brey, R., Rand, J., Schneider, J., Yu, L., Leurgans, S., Bennett, D. Tags: Cerebrovascular Disease and Interventional Neurology: Cognitive and Behavioral Source Type: research
Utility of Pelvic MRV in Evaluation of Patients with Cryptogenic Stroke and PFO (P4.228)
CONCLUSIONS: Our data expands on prior study showing that pelvic MRV has the potential to identify a stroke source in patients with cryptogenic stroke, absent identifiable hypercoagulability state, and PFO.Disclosure: Dr. Osgood has nothing to disclose. Dr. Budman has nothing to disclose. Dr. Henninger has received personal compensation for activities with Brainsgate as a consultant.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Osgood, M., Budman, E., Henninger, N. Tags: Cerebrovascular Disease and Interventional Neurology: Cardiac Source Type: research
Thrombophilia in Young Patients with Cerebrovascular Disease. AISYF Study (S55.005)
Conclusion: Our study showed alterations in 17/125(14%) patients with arterial CVA, excluded PAI abnormalities.With the exception of antiphospholipid antibodies the value of testing TF as part of the evaluation of patients with arterial CVA, even in patients with a cryptogenic event,is still controversial and should not lead to anticoagulation of all these patients.Study Supported by Shire HGTDisclosure: Dr. Leon Cejas has nothing to disclose. Dr. Reisin has received personal compensation for activities with Shire Pharmaceuticals Group. Dr. Reisin has received personal compensation in an editorial capacity for Neurology. D...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Leon Cejas, L., Reisin, R. Tags: Pediatric Stroke and Stroke in the Young Source Type: research
Neurological Disorders Due to Systemic Disease (Book)
If you are a splitter, and you are still in the vanishing market for a desktop reference, you will be in heaven with this new book. The book is organized into 15 presenting clinical problems that may be due to underlying systemic illness, or to the treatments used for those illnesses: headache, encephalopathy, dementia, stroke, seizures, neuro-ophthalmology problems, neuro-otologic presentation, movement disorders, myelopathies, peripheral nerve disorders, neuromuscular junction disorders, myopathies, autonomic manifestations, and sleep disorders. The stated reason for this organization is that neurologists may often be th...
Source: Neurology - February 17, 2014 Category: Neurology Authors: Franklin, G. M. Tags: BOOKS & amp;amp; DIGITAL MEDIA Source Type: research
Stroke in Non-Bacterial Thrombotic Endocarditis: 31-Year Experience (P02.023)
CONCLUSIONS: This 31-year analysis shows that stroke is a frequent complication of NBTE, has severe clinical and radiological manifestations, and high associated mortality. Anticoagulation may not prevent stroke recurrence.Disclosure: Dr. Topcuoglu has nothing to disclose. Dr. Kursun has nothing to disclose. Dr. Karatas has nothing to disclose. Dr. Buonanno has nothing to disclose. Dr. Singhal has received personal compensation as an expert witness in medicolegal cases involving stroke in young adults. Dr. Singhal's wife is an employee of Vertex Pharmaceuticals, Inc. Dr. Singhal has received research support from Pfizer and Photothera, Inc.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Topcuoglu, M., Kursun, O., Karatas, H., Buonanno, F., Singhal, A. Tags: P02 Cerebrovascular Disease II Source Type: research
